alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 10.2

 

THIRD AMENDMENT TO THE

EMPLOYMENT AGREEMENT

 

This THIRD AMENDMENT TO THE EMPLOYMENT AGREEMENT (this “Amendment”) is entered into on February 27, 2015 (the “Amendment Effective Date”), by and between DDR Corp., an Ohio corporation (“DDR” or the “Company”), and Christa A. Vesy (“Executive”).

 

Executive has been and is now employed by and serving DDR as its Executive Vice President & Chief Accounting Officer.  Executive and DDR are currently parties to an Employment Agreement, dated February 29, 2012 and amended by the First Amendment thereto, dated February 27, 2013 and further amended by the Second Amendment Thereto, dated February 28, 2014 (the “Current Agreement”), that reflects the terms pursuant to which Executive has been serving DDR.  The Board of Directors of DDR (the “Board”), on behalf of the Company, and Executive desire to enter into this Amendment to amend the Current Agreement to reflect the terms pursuant to which Executive will continue to be employed by and serve DDR (the Current Agreement as so amended, the “Amended Agreement”).  Certain capitalized terms used in this Amendment without definition have the meanings ascribed to them in the Current Agreement.

 

DDR and Executive agree, effective as of the Amendment Effective Date, as follows:

 

1.  Amendment and Restatement of Section 1 of the Current Agreement.  Section 1 of the Current Agreement is hereby amended and restated in its entirety as follows:

“1.  Employment, Term.  DDR engages and employs Executive to render services in the administration and operation of its affairs as its Executive Vice President & Chief Accounting Officer, reporting directly to DDR’s Chief Executive Officer (the “CEO”) or such other person designated by the CEO, in accordance with the terms and conditions of this Agreement, for a term extending from the Effective Date through December 31, 2015.  The period of time from the Effective Date until December 31, 2015 is sometimes referred to herein as the “Contract Period.” 

2.  Counterparts.  This Amendment may be executed in separate counterparts, each of which shall be deemed an original, and both of which together shall constitute one and the same instrument.

3.  Entire Agreement.  The Amended Agreement, consisting of the Current Agreement as amended as of the Amendment Effective Date by the Amendment, constitutes the full and entire understanding and agreement between the parties with regard to the subjects hereof and thereof.

4.  Continuing Effectiveness.  Except as otherwise provided herein, the Current Agreement shall continue in full force and effect in accordance with its terms.

[THE REMAINDER OF THIS PAGE INTENTIONALLY LEFT BLANK]

 

 

 




 

IN WITNESS WHEREOF, DDR and Executive have executed this Amendment as of the date first written above.

 


		
	
DDR CORP.

	
 
	
 

	
By:
	
/s/ David J. Oakes

	
 
	
David J. Oakes

	
 
	
President and Chief Executive Officer

	
 
	
 

	
By:
	
/s/ Christa A. Vesy

	
 
	
Christa A. Vesy




 

 

2
[Federal Register Volume 74, Number 193 (Wednesday, October 7, 2009)]
[Notices]
[Page 51612]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-24167]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Notice of Closed 
Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Heart, Lung, and Blood Initial Review Group 
Clinical Trials Review Committee.
    Date: October 26, 2009.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 
Wisconsin Avenue, Bethesda, MD 20814.
    Contact Person: Keary A Cope, PhD, Scientific Review Officer, 
Review Branch/DERA, National Heart, Lung, and Blood Institute, 6701 
Rockledge Drive, Room 7190, Bethesda, MD 20892-7924, 301-435-2222, 
<a href="/cdn-cgi/l/email-protection#492a26392c2228092428202567272021672e263f"><span class="__cf_email__" data-cfemail="fe9d918e9b959fbe939f9792d0909796d0999188">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, 
National Center for Sleep Disorders Research; 93.837, Heart and 
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, 
Blood Diseases and Resources Research, National Institutes of 
Health, HHS)

    Dated: October 1, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-24167 Filed 10-6-09; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
§ 150.600 How may funds be invested when I act in an exempt fiduciary capacity? If you act in an exempt fiduciary capacity under § 150.580, the funds of the fiduciary account may be invested only in the following: ( a ) Your accounts, deposits, obligations, or securities.
( b ) Other assets as the customer may direct, provided you do not exercise any investment discretion and do not directly or indirectly provide any investment advice for the fiduciary account.
#### § 1808.624 Criminal provisions.

The criminal provisions of 18 U.S.C. 657 regarding embezzlement or misappropriation of funds are applicable to all CDFI Bond Guarantee Program participants and insiders.
§ 1777.22 Limitation on capital distributions. ( a ) *Capital distributions in general.* An Enterprise shall make no capital distribution that would decrease the total capital of the Enterprise to an amount less than the risk-based capital level or the core capital of the Enterprise to an amount less than the minimum capital level without the prior written approval of OFHEO.
( b ) *Capital distributions by an Enterprise that is not adequately capitalized* — ( 1 ) *Prohibited distributions.* An Enterprise that is not classified as adequately capitalized shall make no capital distribution that would result in the Enterprise being classified into a lower capital classification than the one to which it is classified at the time of such distribution.
( 2 ) *Restricted distributions.* An Enterprise classified as significantly or critically undercapitalized shall make no capital distribution without the prior written approval of OFHEO. OFHEO may grant a request for such a capital distribution only if OFHEO determines, in its discretion, that the distribution: ( i ) Will enhance the ability of the Enterprise to meet the risk-based capital level and the minimum capital level promptly;
( ii ) Will contribute to the long-term financial safety and soundness of the Enterprise; or
( iii ) Is otherwise in the public interest.
##### 



EXHIBIT 23.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM The Board of Directors
Lamar Advertising Company: We consent to incorporation by reference in the Registration Statements of Lamar Advertising
Company and Lamar Media Corp. on Forms S-8 (Nos. 333-89034, 333-10337, 333-79571, 333-37858,
333-34840, 333-116007 and 333-116008), S-3 (No. 333-108688 and 333-48288) and S-4 (No. 333-108689,
333-120937, and 333-48266) of (a) our reports dated March 8, 2005 with respect to Lamar Advertising
Company and subsidiary consolidated financial statements and related financial statement schedule,
managements assessment of the effectiveness of internal control over financial reporting and the
effectiveness of internal control over financial reporting, (b) our reports dated March 8, 2005 with
respect to Lamar Media Corp. and subsidiaries consolidated financial statements and related
financial statement schedule, managements assessment of the effectiveness of internal control over
financial reporting and the effectiveness of internal control over financial reporting which
reports appear in the December 31, 2004, annual report on Form 10-K of Lamar Advertising Company. Our reports refer to the adoption of the provisions of SFAS No. 143, Accounting for Assets
Retirement Obligations on January 1, 2003. /s/ KPMG LLP KPMG LLP New Orleans, Louisiana
March 8, 2005
[Federal Register Volume 74, Number 192 (Tuesday, October 6, 2009)]
[Notices]
[Page 51289]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-23997]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Dental & Craniofacial Research; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Dental and Craniofacial 
Research Special Emphasis Panel; Review of P01 applications on 
Interdisciplinary Research on Oral Manifestations of HIV/AIDS in 
Vulnerable Populations.
    Date: November 12, 2009.
    Time: 9 a.m. to 3 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, 
Bethesda, MD 20817.
    Contact Person: Victor Henriquez, PhD, Scientific Review 
Officer, DEA/SRB/NIDCR, 6701 Democracy Blvd., Room 668, Bethesda, MD 
20892-4878, 301-451-2405, <a href="/cdn-cgi/l/email-protection#4d2528233f243c383b0d2324292e3f63232425632a223b"><span class="__cf_email__" data-cfemail="2149444f5348505457614f484542530f4f48490f464e57">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.121, Oral 
Diseases and Disorders Research, National Institutes of Health, HHS)


    Dated: September 29, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-23997 Filed 10-5-09; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Editorial Note on Part 3
Editorial Note: Nomenclature changes to part 3 appear at 61 FR 7216, Feb. 27, 1996; 62 FR 35970, July 3, 1997; 62 FR 47532, Sept. 9, 1997; and 67 FR 46868, July 17, 2002.

§ 3.354 Determinations of insanity. ( a ) *Definition of insanity.* An insane person is one who, while not mentally defective or constitutionally psychopathic, except when a psychosis has been engrafted upon such basic condition, exhibits, due to disease, a more or less prolonged deviation from his normal method of behavior; or who interferes with the peace of society; or who has so departed (become antisocial) from the accepted standards of the community to which by birth and education he belongs as to lack the adaptability to make further adjustment to the social customs of the community in which he resides.
( b ) *Insanity causing discharge.* When a rating agency is concerned with determining whether a veteran was insane at the time he committed an offense leading to his court-martial, discharge or resignation (38 U.S.C. 5303(b)), it will base its decision on all the evidence procurable relating to the period involved, and apply the definition in paragraph (a) of this section.
[26 FR 1589, Feb. 24, 1961]
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONSOLIDATED BALANCE SHEET AT DECEMBER 31, 1997 AND THE CONSOLIDATED STATEMENT
OF OPERATIONS FOR THE YEAR ENDED DECEMBER 31, 1997 AND IS QUALIFIED IN ITS
ENTIRETY BY REFERENCE TO SUCH FORM 10-K FOR THE YEAR ENDED DECEMBER 31,
1997.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-START>                             JAN-01-1997
<PERIOD-END>                               DEC-31-1997
<CASH>                                           5,346
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                     0
<PP&E>                                       1,145,851
<DEPRECIATION>                                  52,650
<TOTAL-ASSETS>                               1,155,904
<CURRENT-LIABILITIES>                                0
<BONDS>                                        434,122
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                         73
<COMMON>                                           209
<OTHER-SE>                                     674,941
<TOTAL-LIABILITY-AND-EQUITY>                 1,155,904
<SALES>                                        106,862
<TOTAL-REVENUES>                               109,292
<CGS>                                                0
<TOTAL-COSTS>                                    3,828
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              25,845
<INCOME-PRETAX>                                 54,234
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                             54,234
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                     98
<CHANGES>                                            0
<NET-INCOME>                                    54,332
<EPS-PRIMARY>                                     2.31
<EPS-DILUTED>                                     2.28


</TABLE>
EX-10.1



 Exhibit 10.1 

AMENDMENT TO 

AMENDMENT, MODIFICATION, AND SUPPLEMENT TO 

SECURITIES PURCHASE AMENDMENT 

Dated April 8, 2015 
 The
undersigned parties hereby amend that certain Amendment, Modification and Supplement to the Securities Purchase Agreement (the “Amendment”), dated as of March 24, 2015 by and among Medbox, Inc., a Nevada corporation (the
“Company”) and Redwood Management, LLC (also acting on behalf of Redwood Fund III Ltd., Redwood Fund II LLC and RDW Capital, LLC) (the “Purchaser”) as of the date hereof as follows: 

 

	 	1.	The number that appears in section 2.1(c) of the Amendment shall be amended to be $450,000, in both places where it appears in Section 2.1(c). 


 

	 	2.	The number that appears in the introduction of Section 2.1 of the Amendment shall be amended to be $3,150,000. 


Furthermore, the parties agree and acknowledge that on or about March 13, 16 and 20, 2015, an additional tranche in the aggregate
Principal Amount of $150,000 was closed and is be deemed to be a separate, “Modified Closing” under the Amendment. 
 All other
figures, terms and conditions in the Amendment shall remain unchanged. 
 This amendment may be executed in counterpart, all of which when
taken together shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to each other party. 

 

					
			MEDBOX, INC.
			
			By:		  

			Name:		Doug Mitchell
			Title:		Chief Financial Officer
	
	 REDWOOD MANAGEMENT, LLC (on behalf of itself and Redwood Fund III Ltd., Redwood Fund II LLC and RDW Capital, LLC)

			
			By:		  

			Name:		John DeNobile
			Title:		Manager
[Federal Register Volume 74, Number 192 (Tuesday, October 6, 2009)]
[Notices]
[Pages 51270-51271]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-23984]


-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. ID-6169-000]


Shoulla, Sarita; Notice of Filing

September 29, 2009.
    Take notice that on September 22, 2009, Sarita Shoulla filed an 
application for authorization to hold interlocking positions, pursuant 
to section 305(b) of the Federal Power Act, 16 U.S.C. 825d and Part 45 
of the regulations of the Federal Energy Regulatory Commission, 18 CFR 
Part 45.
    Any person desiring to intervene or to protest this filing must 
file in accordance with Rules 211 and 214 of the Commission's Rules of 
Practice and Procedure (18 CFR 385.211, 385.214). Protests will be 
considered by the Commission in determining the appropriate action to 
be taken, but will not serve to make protestants parties to the 
proceeding. Any person wishing to become a party must file a notice of 
intervention or motion to intervene, as appropriate. Such notices, 
motions, or protests must be filed on or before the comment date. On or 
before the comment date, it is not necessary to serve motions to 
intervene or protests on persons other than the Applicant.
    The Commission encourages electronic submission of protests and 
interventions in lieu of paper using the ``eFiling'' link at http://www.ferc.gov. Persons unable to file electronically should submit an 
original and 14 copies of the protest or intervention to the Federal 
Energy Regulatory Commission, 888 First Street, NE., Washington, DC 
20426.
    This filing is accessible online at http://www.ferc.gov, using the 
``eLibrary'' link and is available for review in the Commission's 
Public Reference Room in Washington, DC. There is an ``eSubscription'' 
link on the Web site that enables subscribers to receive e-mail 
notification when a document is added to a subscribed docket(s). For 
assistance with any FERC Online service, please e-mail 
<a href="/cdn-cgi/l/email-protection#fcbab9aebfb39290959299af898c8c938e88bc9a998e9fd29b938a"><span class="__cf_email__" data-cfemail="2a6c6f786965444643444f795f5a5a45585e6a4c4f5849044d455c">[email protected]</span></a>, or call (866) 208-3676 (toll free). For 
TTY, call (202) 502-8659.

[[Page 51271]]

    Comment Date: 5 p.m. Eastern Time on October 13, 2009.

Kimberly D. Bose,
Secretary.
[FR Doc. E9-23984 Filed 10-5-09; 8:45 am]
BILLING CODE 6717-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
I 

110TH CONGRESS 

1ST SESSION H. R. 259 

To provide for the establishment of a task force within the Bureau of Justice 

Statistics to gather information about, study, and report to the Congress 

regarding, incidents of abandonment of infant children. 

IN THE HOUSE OF REPRESENTATIVES 

JANUARY 5, 2007 

Ms. JACKSON-LEE of Texas introduced the following bill; which was referred 

to the Committee on the Judiciary, and in addition to the Committee on 

Education and Labor, for a period to be subsequently determined by the 

Speaker, in each case for consideration of such provisions as fall within 

the jurisdiction of the committee concerned 

A BILL 

To provide for the establishment of a task force within 

the Bureau of Justice Statistics to gather information 

about, study, and report to the Congress regarding, incidents of abandonment of infant children. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Baby Abandonment 

5 Prevention Act of 2007’’. 


pwalker on PROD1PC71 with BILLS
2 

•HR 259 IH

1 SEC. 2. ESTABLISHMENT OF TASK FORCE. 

2 (a) IN GENERAL.—The Attorney General, acting 

3 through the Director of the Bureau of Justice Statistics, 

4 shall establish a task force (to be known as the Task Force 

5 on Baby Abandonment) to carry out the following: 

6 (1) Collecting information from State and local 

7 law enforcement agencies and child welfare agencies 

8 regarding incidents of abandonment of an infant 

9 child by a parent of that child. 

10 (2) Maintaining that information in a com11 prehensive database. 

12 (3) Studying that information and making find13 ings, conclusions, and recommendations regarding 

14 that information. 

15 (4) Submitting reports in accordance with this 

16 section. 

17 (b) INFORMATION INCLUDED.—The information re18 ferred to in subsection (a) shall include information with 

19 respect to the following: 

20 (1) The prevalence of such incidents. 

21 (2) The demographics of such children and 

22 such parents. 

23 (3) The factors that influence the decision of 

24 such parents to abandon such children. 


pwalker on PROD1PC71 with BILLS
3 

•HR 259 IH

1 (4) The circumstances surrounding such aban2 donments, including the time, place, and manner of 

3 such abandonments. 

4 (5) The outcomes for such children and such 

5 parents after such abandonments. 

6 (6) Trends and variations in the matters set 

7 forth in paragraphs (1) through (5). 

8 (c) DEFINITION.—In this section, the term ‘‘infant 

9 child’’ means a child not more than 12 months of age. 

10 (d) REPORTS.—Not later than one year after the date 

11 of the enactment of this Act, and annually thereafter, the 

12 task force shall submit a report to the Congress detailing 

13 its methodology, findings, conclusions, and recommenda14 tions. 

Æ 


pwalker on PROD1PC71 with BILLS
# United States Court **of Appeals**  **f or the Fifth Circuit** 

**____________** No. 23

- 10751 Summary Calendar

**____________ United States of America,**  Plaintiff

— Appellee **,**

versus **Xavier Dewayne Cunningham,** Defendant

— Appellant

**.**

**______________________________** Appeal from the United States District Court for the Northern District of Texas USDC No. 2:22

- CR

- 101

- 1

**___________ ___________________**  Before **Higginbotham, Stewart,** and **Southwick,** Circuit Judges

**. Per Curiam**  **:** *****
The Federal Public Defender appointed to represent Xavier Dewayne Cunningham has moved for leave to withdraw and has filed a brief in accordance with Anders v. California , 386 U.S. 738 (1967), and United States v. Flores , 632 F.3d 229 (5th Cir. 2011). Cunningham has not filed a response. We have reviewed counsel’s brief and th e relevant portions of the record

**_____________________**

* This opinion is not designated for publication. See **5th Cir**

**. R** 

**.** 47.5. United States Court of Appeals Fifth Circuit 

### FILED March 11, 2024 Lyle W. Cayce Clerk Case: 23-10751 Document: 41-1 Page: 1 Date Filed: 03/11/2024No. 23

- 10751

2 reflected therein. We concur with counsel’s assessment that the appeal presents no nonfrivolous issue for appellate review. Accordingly, counsel’s motion for leave to file a supplemental Anders brief is **DENIED** , counsel’s motion for leave to withdraw is **GRANTED** , counsel is excused from further responsibilities herein, and the appeal is **DISMISSED**

. See **5th Cir. R.**  42.2

. Case: 23-10751 Document: 41-1 Page: 2 Date Filed: 03/11/2024